和胜股份（维权）（002824）于2025年10月9日发布公告，公司于2025年9月30日召开第五届董事会第十 四次会议，审议通过《关于使用自有资金、银行承兑汇票等方式支付募投项目款项并以募集资金等额置 换的议案》，同意公司在募投项目实施期间，根据实际情况使用自有资金、银行承兑汇票等方式支付募 投项目所需部分资金，并以募集资金等额置换。 募集资金基本情况 经中国证监会《关于同意广东和胜工业铝材股份有限公司向特定对象发行股票注册的批复》（证监许可 〔2025〕1046号）同意注册，本次向特定对象发行人民币普通股30,845,157股，每股面值1元，每股发行 价格为16.21元。本次发行募集资金总额为499,999,994.97元，扣除发行费用（不含增值税）6,132,854.73 元后，募集资金净额为493,867,140.24元。募集资金到位情况经容诚会计师事务所验证，并出具《验资 报告》。公司对募集资金采取专户存储管理，并与保荐机构、募集资金专户所在银行签订《募集资金三 方监管协议》。 支付及置换原因人员薪酬支付限制：募投项目实施需支付人员工资等薪酬费用，按规定基本存款账户用 于日常经营资金收付及工资支取， ...

Core Viewpoint - The management measures for the use of raised funds by Jiangsu Lianhuan Pharmaceutical Co., Ltd. aim to standardize the usage and management of raised funds, enhance their effectiveness, and protect investors' rights [1]. Group 1: General Principles - The purpose of the management measures is to regulate the use and management of raised funds, improve their effectiveness, and protect investors' rights based on relevant laws and regulations [1]. - The term "raised funds" refers to funds raised through public and non-public securities issuance, excluding funds raised for equity incentive plans [1]. - "Excess raised funds" refers to the portion of actual net raised funds that exceeds the planned amount [1]. Group 2: Fund Storage - Raised funds must be stored in a special account approved by the board of directors, and cannot be used for non-raised fund purposes [4]. - A tripartite supervision agreement must be signed with the sponsor or independent financial advisor and the commercial bank within one month of the funds being received [4][5]. - The agreement must include details such as the account number, project details, and monthly bank statements [5]. Group 3: Fund Usage - The company must adhere to specific requirements when using raised funds, including clear regulations on application, approval, and disclosure procedures [11]. - Funds should primarily be used for main business operations and cannot be used for financial investments or to benefit related parties improperly [13]. - Any changes in the use of raised funds must be approved by the board and disclosed to shareholders [24][25]. Group 4: Supervision and Reporting - The company must maintain accurate records of fund usage and undergo quarterly internal audits [16]. - The board is required to conduct a comprehensive review of project progress and fund usage every six months, issuing a special report [32]. - Independent directors and the audit committee must continuously monitor the management and usage of raised funds [33]. Group 5: Excess Funds Management - Excess funds can be used for permanent working capital or repaying bank loans, with specific limits on the amount used [10][11]. - Any use of excess funds must be approved by the board and disclosed to shareholders, including the necessity and detailed plans for such use [11].

Core Viewpoint - The company has approved the use of its own funds to pay for investment project expenses during the implementation period, with plans to replace these funds with raised capital later, ensuring efficient use of funds and compliance with regulations [5][7][8]. Fundraising Overview - The company has successfully issued 55.21 million shares at a price of 26.74 RMB per share, raising a total of 1,477.5 million RMB [1][2]. - All raised funds are stored in a special account approved by the board, with a tripartite supervision agreement in place [2]. Investment Projects and Fund Usage - The total investment for the projects is 100 million RMB, with the same amount planned to be funded by the raised capital [2][4]. - The company has decided to extend the implementation period and adjust the investment structure of some projects, including the addition of a new project for the development and industrialization of Inertial Measurement Units (IMU) [2][3]. Reasons for Using Own Funds - The company needs to use its own funds for certain expenses due to regulatory requirements, such as salary payments and taxes, which cannot be paid from the raised funds account [5][6]. - Using own funds for shared expenses like rent and utilities simplifies the payment process, as multiple projects share the same location [5][6]. Impact on the Company - The decision to use own funds and later replace them with raised funds is expected to enhance the efficiency of fund usage and reduce financial costs without affecting the normal implementation of investment projects [7][8]. Approval Process - The board and supervisory committee have reviewed and approved the proposal, confirming that it aligns with relevant regulations and does not alter the intended use of raised funds [7][8][9].

上海交大昂立股份有限公司 募集资金使用管理办法 第一章 总则 第一条 为规范上海交大昂立股份有限公司(以下简称"公司")募集资金的使用与 管理，最大限度地保障投资者的利益，根据《中华人民共和国公司法》《中华人民共和 国证券法》《首次公开发行股票注册管理办法》《上市公司证券发行注册管理办法》《上 市公司募集资金监管规则》《上海证券交易所股票上市规则》等有关法律、法规、规范 性文件以及《上海交大昂立股份有限公司章程》 （以下简称"《公司章程》"）的规定，制 定本制度。 第二条 本办法所称募集资金，是指公司通过公开发行证券（包括首次公开发行股 票、配股、增发、发行可转换公司债券、发行分离交易的可转换公司债券等）以及非公 开发行证券向投资者募集的资金，但不包括公司实施股权激励计划募集的资金。 本办法也适用于公司实际募集资金净额超出计划募集资金金额部分的资金（以下简 称"超募资金"）的使用与管理。 第三条 公司募集资金应当按照本办法的规定进行存储、使用和管理，做到资金使 用的规范、公开和透明。 公司董事会应当对募集资金投资项目的可行性进行充分论证，确信投资项目具有较 好的市场前景和盈利能力，有效防范投资风险，提高募集资 ...

Core Points - The board of directors of Yifeng Pharmacy held its 19th meeting of the 5th session on July 30, 2025, with all 9 directors present, and the meeting was conducted in accordance with legal and regulatory requirements [1][4] - The board approved several key proposals, including the cancellation of the supervisory board and amendments to the company's articles of association, which will be submitted for shareholder approval [2][5] - The board also approved the extension of the completion date for the "Yifeng Digital Platform Upgrade Project" from July 31, 2025, to December 31, 2025, without changing the project implementation subject, method, total amount of raised funds, or purpose [3][4] - A proposal was made to use up to 7.05 million yuan of the company's own funds to cover certain costs related to the digital platform upgrade project, with plans to replace these funds with equivalent amounts from the raised funds [3][4] - The company will hold its second extraordinary general meeting of 2025 on August 25, 2025, at 14:30, in Changsha, Hunan Province, with the board authorized to handle related matters [5]

Meeting Overview - The company will hold its second extraordinary general meeting of shareholders on July 2, 2025, at 14:30 [1] - The meeting will include both on-site and online voting options for shareholders [1][5] - Shareholders must register to attend the meeting, with specific requirements for both corporate and individual shareholders [4][5] Agenda Items - The meeting will review several proposals, including amendments to various management systems and the approval of a project loan application by a wholly-owned subsidiary [2][3] - Proposals require a special resolution, needing more than two-thirds of the voting rights held by attending shareholders to pass [3] Registration and Voting Procedures - Registration for the meeting can be done in person or through mail, fax, or email for remote shareholders [4][5] - The company will provide a platform for online voting through the Shenzhen Stock Exchange systems [5][10] - Detailed instructions for the voting process, including the allocation of voting rights, are provided [10][11]